GL

MKT CAP:$12B

Globe Life Inc.

Market Cap

$12B

Financial Services·Insurance - Life·🇺🇸 United States·NYSE

Financials·Insurance - Life·🇺🇸·NYSE

Stock Price

$152.56+$14.14 (+10.22%)

Apr 24, 2026

Company Details

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life In...

CEO

Frank Martin Svoboda

IPO Date

Oct 1, 1980

Website

www.home.globelifeinsurance.com

Key Metrics TTM

Revenue

$6.1B

+4.0% YoY

Net Income

$1.2B

EPS (Diluted)

$14.50

Free Cash Flow

$1.3B

Revenue / Share

$76.16

Gross Margin

38.1%

Operating Margin

24.9%

Net Margin

19.4%

FCF Margin

20.6%

P/S

2.0x

P/E

10.1x

Earnings Reports

Q1 2026

Apr 22, 2026

NEW

$1.6B+5.3%EPS $3.45

FY 2025

Feb 25, 2026

$6.0B+3.8%EPS $14.06

Q4 2025

Feb 25, 2026

$1.5B+3.9%EPS $3.29

Q3 2025

Nov 5, 2025

$1.5B+4.0%EPS $4.71

Q2 2025

Aug 6, 2025

$1.5B+2.8%EPS $3.05

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$1.3B	$398M	$294M
Q2 22	$1.3B	$388M	$276M
Q3 22	$1.3B	$347M	$235M
Q1 23	$1.1B	$383M	$274M
Q2 23	$1.3B	$376M	$265M
Q3 23	$1.4B	$431M	$319M
Q4 23	$1.4B	$451M	$337M
Q1 24	$1.4B	$675M	$315M
Q2 24	$1.4B	$453M	$322M
Q3 24	$1.5B	$513M	$377M
Q4 24	$1.5B	$467M	$312M
Q1 25	$1.5B	$460M	$316M
Q2 25	$1.5B	$456M	$313M
Q3 25	$1.5B	$625M	$477M
Q4 25	$1.5B	$463M	$356M
Q1 26	$1.6B	$770M	$368M

Valuation

Quarter	P/S	P/E
Q1 22	2.0x	12.6x
Q2 22	1.9x	11.7x
Q3 22	1.9x	11.9x
Q1 23	2.1x	11.9x
Q2 23	2.1x	12.2x
Q3 23	2.0x	11.5x
Q4 23	2.2x	11.7x
Q1 24	1.9x	10.7x
Q2 24	1.3x	7.0x
Q3 24	1.6x	8.2x
Q4 24	1.6x	8.6x
Q1 25	1.9x	10.3x
Q2 25	1.8x	9.7x
Q3 25	2.0x	10.4x
Q4 25	2.0x	10.2x
Q1 26	1.8x	9.4x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 21	$378M	$370M
Q1 22	$397M	$390M
Q2 22	$296M	$290M
Q3 22	$357M	$351M
Q1 23	$477M	$469M
Q2 23	$327M	$309M
Q3 23	$287M	$276M
Q4 23	$391M	$378M
Q1 24	$351M	$342M
Q2 24	$374M	$356M
Q3 24	$341M	$311M
Q4 24	$337M	$322M
Q1 25	$432M	$420M
Q2 25	$308M	$295M
Q3 25	$306M	$209M
Q4 25	$351M	$330M

Capital Expenditures

Quarter	CapEx
Q4 21	$8M
Q1 22	$7M
Q2 22	$7M
Q3 22	$6M
Q1 23	$8M
Q2 23	$17M
Q3 23	$11M
Q4 23	$13M
Q1 24	$9M
Q2 24	$18M
Q3 24	$29M
Q4 24	$15M
Q1 25	$12M
Q2 25	$13M
Q3 25	$97M
Q4 25	$21M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+2.8%	-3.8%
Q2 22	+1.6%	-1.0%
Q3 22	+0.8%	+0.6%
Q1 23	-15.7%	-24.1%
Q2 23	+1.8%	+5.3%
Q3 23	+7.1%	+4.9%
Q4 23	+9.1%	+1.6%
Q1 24	+29.5%	+34.4%
Q2 24	+8.6%	+5.3%
Q3 24	+5.2%	+1.2%
Q4 24	+3.6%	+6.9%
Q1 25	+4.5%	+5.7%
Q2 25	+2.8%	+4.5%
Q3 25	+4.0%	-3.9%
Q4 25	+3.9%	+1.2%
Q1 26	+5.3%	+2.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 21	$0	0.0%
Q1 22	$0	0.0%
Q2 22	$0	0.0%
Q3 22	$0	0.0%
Q1 23	$0	0.0%
Q2 23	$0	0.0%
Q3 23	$0	0.0%
Q4 23	$0	0.0%
Q1 24	$0	0.0%
Q2 24	$0	0.0%
Q3 24	$0	0.0%
Q4 24	$0	0.0%
Q1 25	$0	0.0%
Q2 25	$0	0.0%
Q3 25	$0	0.0%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	G&A	S&M
Q1 22	$82M	—
Q1 23	$82M	—
Q4 23	$85M	—
Q1 24	$90M	—
Q4 24	$97M	—
Q1 25	$106M	—
Q4 25	$92M	—
Q1 26	$114M	$288M

Revenue Segments

Quarter	Health Segment	Investment Segment	Life Segment	Annuity Segment
Q1 22	$317M	$244M	$755M	—
Q2 22	$319M	$244M	$760M	—
Q3 22	$319M	$246M	$755M	$1.0K
Q2 23	$329M	$261M	$782M	—
Q3 23	$331M	$267M	$788M	—
Q1 24	$341M	$283M	$804M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$128M	$19.2B	$19.4B
Q2 22	$172M	$17.3B	$17.5B
Q3 22	$86M	$16.1B	$16.2B
Q4 22	$93M	$16.6B	$16.7B
Q1 23	$172M	$17.3B	$17.5B
Q2 23	$75M	$17.1B	$17.2B
Q3 23	$86M	$16.3B	$16.4B
Q4 23	$103M	$18.0B	$18.1B
Q1 24	$84M	$18.2B	$18.3B
Q2 24	$88M	$17.7B	$17.8B
Q3 24	$135M	$18.4B	$18.6B
Q4 24	$165M	$17.2B	$17.4B
Q1 25	$232M	$17.6B	$17.9B
Q2 25	$239M	$17.5B	$17.7B
Q3 25	$303M	$17.9B	$18.2B
Q4 25	$145M	$17.9B	$18.0B

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	100M	-1.1%	-4.4%
Q2 22	99M	-1.3%	-5.1%
Q3 22	98M	-0.8%	-4.1%
Q1 23	98M	-0.2%	-3.4%
Q2 23	96M	-1.7%	-4.0%
Q3 23	96M	-0.4%	-3.2%
Q4 23	95M	-0.4%	-2.7%
Q1 24	95M	-0.4%	-2.9%
Q2 24	94M	-1.3%	-2.5%
Q3 24	88M	-6.2%	-8.1%
Q4 24	85M	-3.8%	-11.2%
Q1 25	84M	-0.3%	-11.2%
Q2 25	83M	-2.0%	-11.8%
Q3 25	82M	-0.9%	-6.9%
Q4 25	81M	-1.4%	-4.6%
Q1 26	80M	-1.3%	-5.5%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$404.3K	3K
Q2 22	$400.9K	3K
Q3 22	$402.6K	3K
Q1 23	$308.6K	4K
Q2 23	$374.4K	4K
Q3 23	$390.7K	4K
Q4 23	$389.4K	4K
Q1 24	$389.5K	4K
Q2 24	$396.1K	4K
Q3 24	$400.3K	4K
Q4 24	$392.9K	4K
Q1 25	$396.7K	4K
Q2 25	$396.9K	4K
Q3 25	$405.4K	4K
Q4 25	$408.3K	4K
Q1 26	$417.9K	4K

Revenue / Employee